Drug induced perturbations in tumor blood flow: therapeutic potential and possible limitations

This publication has 31 references indexed in Scilit:

• Nicotinamide, Fluosol DA and Carbogen: a strategy to reoxygenate acutely and chronically hypoxic cells in vivo
  British Journal of Cancer, 1991
• Manipulation of oxygenation in a human tumour xenograft with BW12C or hydralazine : effects on responses to radiation and to the bioreductive cytotoxicity of misonidazole or RSU-1069
  Radiotherapy and Oncology, 1989
• Hydralazine-Induced Tumor Hypoxia: A Potential Target for Cancer Chemotherapy
  JNCI Journal of the National Cancer Institute, 1989
• The effect of hydralazine on the tumor cytotoxicity of the hypoxic cell cytotoxin RSU-1069: Evidence for therapeutic gain
  International Journal of Radiation Oncology*Biology*Physics, 1987
• Potentiation of RSU-1069 tumour cytotoxicity by 5-hydroxytryptamine (5-HT)
  British Journal of Cancer, 1986
• Acute hypoxia in tumors: Implications for modifiers of radiation effects
  International Journal of Radiation Oncology*Biology*Physics, 1986
• The radiosensitizing and toxic effects of RSU-1069 on hypoxic cells in a murine tumor
  International Journal of Radiation Oncology*Biology*Physics, 1986
• Radiation sensitization and chemopotentiation: Rsu 1069, a compound more efficient than misonidazole in vitro and in vivo
  British Journal of Cancer, 1984
• Abnormal Response of Tumor Vasculature to Vasoactive Drugs23
  JNCI Journal of the National Cancer Institute, 1984
• Changes of Oxygen Tension in Tumours Induced by Vasoconstrictor and Vasodilator Drugs
  Acta Radiologica, 1962